The Class is defined as all persons who purchased, for personal consumption and not for resale, one or more of the covered Neuriva products from Reckitt Benckiser or an authorized reseller in the United States, between Jan. 1, 2019, and April 23, 2021.
The plaintiffs in a class action lawsuit accused the defendants of falsely advertising Neuriva products as being clinically and scientifically proven to enhance brain performance, in violation of consumer protection laws and other laws.
